Combination of betulinic acid and chidamide synergistically inhibits Epstein-Barr virus replication through over-generation of reactive oxygen species

Epstein-Barr virus (EBV) has widely infected more than 90% of human populations. Currently, there is no efficient way to remove the virus because the EBV carriers are usually in a latent stage that allows them to escape the immune system and common antiviral drugs. In the effort to develop an effici...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Haibing, Zhang, Hongyu, Chu, Zhigang, Ruan, Qiongfang, Chen, Xueru, Kong, Danli, Huang, Xiaodong, Li, Huawen, Tang, Huanwen, Wu, Hongjin, Wang, Yifei, Xie, Weiguo, Ding, Yuanling, Yao, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617453/
https://www.ncbi.nlm.nih.gov/pubmed/28977893
http://dx.doi.org/10.18632/oncotarget.18661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617453/
https://www.ncbi.nlm.nih.gov/pubmed/28977893
http://dx.doi.org/10.18632/oncotarget.18661

Ejemplares similares